Reviewing new challenges and opportunities for hepatitis B cures

Hepatitis B virus (HBV) is a significant public health problem, with over 296 million people chronically infected worldwide. Despite the availability of a safe and effective vaccine for over 40 years, HBV remains a leading ...


Roche to pay $7.1 bn for Telavant Holdings

Swiss pharmaceutical group Roche said Monday it will pay $7.1 billion to buy Telavant Holdings, a group developing new treatments for inflammatory bowel diseases.


How antibodies offer protection against an infection with HIV

A team of researchers investigating the transmission of HIV have discovered that HIV antibodies provide sterilizing immunity by inhibiting the infection of the first cell. The research is published in the journal Cell Reports ...


Kidney disease gene found to also have a protective mutation

African Americans have long been known to be at increased risk of kidney disease due to a dangerous genetic mutation that creates a hole in the kidney cells, but Vanderbilt University Medical Center (VUMC) researchers have ...

page 1 from 30